Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressDividends payablesGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityMinority InterestNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

National Healthcare Properties (NHPAP) Dividends payables (2016 - 2025)

Historic Dividends payables for National Healthcare Properties (NHPAP) over the last 13 years, with Q3 2025 value amounting to $3.4 million.

  • National Healthcare Properties' Dividends payables fell 354.69% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year decrease of 354.69%. This contributed to the annual value of $3.5 million for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, National Healthcare Properties' Dividends payables stood at $3.4 million, which was down 354.69% from $3.4 million recorded in Q2 2025.
  • National Healthcare Properties' Dividends payables' 5-year high stood at $3.5 million during Q1 2022, with a 5-year trough of $742000.0 in Q1 2021.
  • In the last 5 years, National Healthcare Properties' Dividends payables had a median value of $3.5 million in 2022 and averaged $3.2 million.
  • As far as peak fluctuations go, National Healthcare Properties' Dividends payables crashed by 9000.81% in 2021, and later surged by 37115.9% in 2022.
  • Quarter analysis of 5 years shows National Healthcare Properties' Dividends payables stood at $3.4 million in 2021, then increased by 2.64% to $3.5 million in 2022, then changed by 0.0% to $3.5 million in 2023, then changed by 0.0% to $3.5 million in 2024, then fell by 3.55% to $3.4 million in 2025.
  • Its Dividends payables was $3.4 million in Q3 2025, compared to $3.4 million in Q2 2025 and $3.5 million in Q1 2025.